Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank Herrmann

Showing results (41-50 of 57) with videos related to

Pageof 6
Sort By:
Neurobiology of Disease|March 26, 2023
Understanding the role of the hematopoietic niche in Huntington's disease's phenotypic expression: in vivo evidence using a parabiosis modelMarie Rieux, Melanie Alpaugh, Shireen Salem, et al.
Human Reproduction (Oxford, England)|April 12, 2026
Variations in ovulation time and menstrual cycle characteristics: analysis of a prospective long-term cohort studyMaria-Nefeli Malliou-Becher, Pia Maria Herrmann, Alexander Freis, et al.
Human Reproduction (Oxford, England)|February 13, 2019
Gonadoblastoma Y locus genes expressed in germ cells of individuals with dysgenetic gonads and a Y chromosome in their karyotypes include DDX3Y and TSPYP H Vogt, B Besikoglu, M Bettendorf, et al.
Systems Biology in Reproductive Medicine|April 28, 2022
Sex chromosome DSD individuals with mosaic 45,X0 and aberrant Y chromosomes in 46,XY cells: distinct gender phenotypes and germ cell tumour risks<sup>§</sup>Peter H Vogt, Banu Besikoglu, Markus Bettendorf, et al.
Plos One|May 13, 2014
Quantification assays for total and polyglutamine-expanded huntingtin proteinsDouglas Macdonald, Michela A Tessari, Ivette Boogaard, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|December 18, 2017
A standardised frankincense extract reduces disease activity in relapsing-remitting multiple sclerosis (the SABA phase IIa trial)Klarissa Hanja Stürner, Jan-Patrick Stellmann, Jan Dörr, et al.
Molecular Psychiatry|June 10, 2020
Shedding a new light on Huntington's disease: how blood can both propagate and ameliorate disease pathologyMarie Rieux, Melanie Alpaugh, Giacomo Sciacca, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 25, 2020
Expression of mutant exon 1 huntingtin fragments in human neural stem cells and neurons causes inclusion formation and mitochondrial dysfunctionRhia Ghosh, Alison Wood-Kaczmar, Lucianne Dobson, et al.
Plos One|March 27, 2019
Meso scale discovery-based assays for the detection of aggregated huntingtinWolfgang Reindl, Barbara Baldo, Jana Schulz, et al.
Science Translational Medicine|February 2, 2022
Development of a ligand for in vivo imaging of mutant huntingtin in Huntington's diseaseDaniele Bertoglio, Jonathan Bard, Manuela Hessmann, et al.
Pageof 6

Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
Neurobiology of Disease|March 26, 2023
Understanding the role of the hematopoietic niche in Huntington's disease's phenotypic expression: in vivo evidence using a parabiosis modelMarie Rieux, Melanie Alpaugh, Shireen Salem, et al.
Human Reproduction (Oxford, England)|April 12, 2026
Variations in ovulation time and menstrual cycle characteristics: analysis of a prospective long-term cohort studyMaria-Nefeli Malliou-Becher, Pia Maria Herrmann, Alexander Freis, et al.
Human Reproduction (Oxford, England)|February 13, 2019
Gonadoblastoma Y locus genes expressed in germ cells of individuals with dysgenetic gonads and a Y chromosome in their karyotypes include DDX3Y and TSPYP H Vogt, B Besikoglu, M Bettendorf, et al.
Systems Biology in Reproductive Medicine|April 28, 2022
Sex chromosome DSD individuals with mosaic 45,X0 and aberrant Y chromosomes in 46,XY cells: distinct gender phenotypes and germ cell tumour risks<sup>§</sup>Peter H Vogt, Banu Besikoglu, Markus Bettendorf, et al.
Plos One|May 13, 2014
Quantification assays for total and polyglutamine-expanded huntingtin proteinsDouglas Macdonald, Michela A Tessari, Ivette Boogaard, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|December 18, 2017
A standardised frankincense extract reduces disease activity in relapsing-remitting multiple sclerosis (the SABA phase IIa trial)Klarissa Hanja Stürner, Jan-Patrick Stellmann, Jan Dörr, et al.
Molecular Psychiatry|June 10, 2020
Shedding a new light on Huntington's disease: how blood can both propagate and ameliorate disease pathologyMarie Rieux, Melanie Alpaugh, Giacomo Sciacca, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 25, 2020
Expression of mutant exon 1 huntingtin fragments in human neural stem cells and neurons causes inclusion formation and mitochondrial dysfunctionRhia Ghosh, Alison Wood-Kaczmar, Lucianne Dobson, et al.
Plos One|March 27, 2019
Meso scale discovery-based assays for the detection of aggregated huntingtinWolfgang Reindl, Barbara Baldo, Jana Schulz, et al.
Science Translational Medicine|February 2, 2022
Development of a ligand for in vivo imaging of mutant huntingtin in Huntington's diseaseDaniele Bertoglio, Jonathan Bard, Manuela Hessmann, et al.
Pageof 6